VANCOUVER, BC, Nov. 4, 2021 /CNW/ - The following issues have been halted by IIROC: Company: Novamind Inc. CSE Symbol: NM All Issues: Yes Reason: Cease Trade Order Halt Time (ET): 7:45 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-list...Read More
Toronto, Ontario--(Newsfile Corp. - le 4 novembre/November 2021) Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issu...Read More
Industry-leading revenue, $6,069,247 in FY2021Total working capital of $9,680,431 to fund operationsExpanded network to six clinics and three clinical research sitesContracted for eight clinical trialsGranted DEA Schedule 1 licenses for psilocybin researchTORONTO, ON / ACCESSWIRE...Read More
TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to unveil Alto Neuroscience ("Alto"), a clinical-stage bioph...Read More
TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Generation Mining Limited (TSX: GENM; OTCQB: GENMF) (“Gen Mining” or the “Company”) is pleased to announce that Wood, the global consulting and engineering company, has been awarded and has commenced with the processing...Read More
Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substancesTORONTO, ON / ACCESSWIRE / October 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedel...Read More
TORONTO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Generation Mining Limited (TSX: GENM; OTCQB: GENMF) (“Gen Mining” or the “Company”) is pleased to announce results from the summer drill program of the Central Feeder Zone immediately adjacent to the Marathon palladium-...Read More
TORONTO, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Generation Mining Limited (TSX: GENM; OTCQB: GENMF) (“Gen Mining” or the “Company”) is pleased to announce the addition of a new senior member to the management team, and that it has delivered concentrate samples to mul...Read More
TORONTO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Generation Mining Limited (TSX: GENM; OTCQB: GENMF) (“Gen Mining” or the “Company”) is pleased to announce results from the first three holes drilled in the Chonolith area immediately north of the Marathon palladium-co...Read More
TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Generation Mining Limited (TSX: GENM; OTCQB: GENMF) (“Gen Mining” or the “Company”) is pleased to announce the hiring of Jeremy Dart as Environmental Manager and Cathryn Moffett as Manager of Community Consultation, and...Read More
TORONTO, ON / ACCESSWIRE / October 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced participation in two upcoming virtual investor conferences on Wedn...Read More
Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illnessTORONTO, ON / ACCESSWIRE / October 7, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental...Read More
Chief Medical Officer will join expert panel on data and tech in psychedelic-assisted psychotherapyTORONTO, ON / ACCESSWIRE / October 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psych...Read More
TORONTO, ON / ACCESSWIRE / September 30, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has opened its sixth integrative psychiatry clin...Read More
Toronto, Ontario--(Newsfile Corp. - September 29, 2021) - Novamind Inc. (CSE: NM) (OTCQB: NVMDF) (FSE: HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will participate in the Benzinga Small Cap Healthcare Conference taking place virtually on S...Read More
TORONTO, ON / ACCESSWIRE / September 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that its common shares are now eligible for electronic c...Read More
Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcareTORONTO, ON / ACCESSWIRE / September 23, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company...Read More
TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has been included in the AdvisorShares Psychedel...Read More
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Novamind Inc. (CSE: NM | OTCQB: NVMDF | FSE: HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is pleased to announce its participation in the Life Sciences Invest...Read More
TORONTO, ON / ACCESSWIRE / September 14, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce its participation in the Life Sciences Investor Forum, t...Read More